| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institute of Molecular Radiobiology, GSF National Research Center for Environment and Health, Neuherberg, Germany
Ig hypermutation is limited to a region of 
2 kb downstream of the transcription start sites of the Ig loci. The process requires transcription and the presence of Ig enhancer sequences, and is initiated by the activation-induced cytidine deaminase (AID)-mediated deamination of cytidine bases. It remains unknown why AID causes mutations selectively in the Ig genes and not in most other transcribed loci of B cells. In this study, we report that the inactivation of the E2A gene strongly reduces the rate of Ig L chain mutations in the chicken B cell line DT40 without affecting the levels of surface Ig or AID expression. The defect is complemented by the expression of cDNAs corresponding to either of the two E2A splice variants E12 or E47. The results suggest that E2A-encoded proteins enhance Ig hypermutation by recruitment of AID to the Ig loci.
This article has been cited by other articles:
|
|
 |
|
  H. Arakawa and J.-M. Buerstedde Activation-induced cytidine deaminase-mediated hypermutation in the DT40 cell line Phil Trans R Soc B, March 12, 2009; 364(1517): 639 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yabuki, E. C. Ordinario, W. J. Cummings, M. M. Fujii, and N. Maizels E2A Acts in cis in G1 Phase of Cell Cycle to Promote Ig Gene Diversification J. Immunol., January 1, 2009; 182(1): 408 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xiang and W. T. Garrard The Downstream Transcriptional Enhancer, Ed, Positively Regulates Mouse Ig{kappa} Gene Expression and Somatic Hypermutation J. Immunol., May 15, 2008; 180(10): 6725 - 6732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kothapalli, D. D. Norton, and S. D. Fugmann Cutting Edge: A cis-Acting DNA Element Targets AID-Mediated Sequence Diversification to the Chicken Ig Light Chain Gene Locus J. Immunol., February 15, 2008; 180(4): 2019 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kitao, M. Kimura, K. Yamamoto, H. Seo, K. Namikoshi, Y. Agata, K. Ohta, and M. Takata Regulation of histone H4 acetylation by transcription factor E2A in Ig gene conversion Int. Immunol., February 1, 2008; 20(2): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ohm-Laursen and T. Barington Analysis of 6912 Unselected Somatic Hypermutations in Human VDJ Rearrangements Reveals Lack of Strand Specificity and Correlation between Phase II Substitution Rates and Distance to the Nearest 3' Activation-Induced Cytidine Deaminase Target J. Immunol., April 1, 2007; 178(7): 4322 - 4334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakayama, H. Suzuki, N. Yamamoto-Nagamatsu, H. K. Barman, H. Kikuchi, Y. Takami, K. Toyonaga, K. Yamashita, and T. Nakayama HDAC2 controls IgM H- and L-chain gene expressions via EBF1, Pax5, Ikaros, Aiolos and E2A gene expressions Genes Cells, March 1, 2007; 12(3): 359 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Yang, S. D. Fugmann, and D. G. Schatz Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences J. Exp. Med., December 25, 2006; 203(13): 2919 - 2928. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
